News Focus
News Focus
Replies to #63239 on Biotech Values
icon url

masterlongevity

06/05/08 6:52 PM

#63240 RE: DewDiligence #63239

A lot of analysts changes their approval prediction from around 70% to 40% following AAN, based on the safety events seen. I would say this drops it even furhter.

Certainly this is not going to be the mega blockbuster once predicted.
icon url

DewDiligence

08/17/08 12:07 PM

#65401 RE: DewDiligence #63239

Update on FTY720 and the new oral therapies
for MS (from Nature Biotechnology):

#msg-31515145